Institutional investors purchased a net $13.9 million shares of BMY during the quarter ended December 2016 and now own 72.12% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Major industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
DODGE & COX Bought 22.5 Million shares of Bristol-Myers Squibb
CAPITAL RESEARCH & MANAGEMENT CO... Bought 15.3 Million shares of Bristol-Myers Squibb
WELLINGTON MANAGEMENT CO. LLP Bought 11.8 Million shares of Bristol-Myers Squibb